These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 6961854)

  • 1. The interaction of a treatment program using opiates for mental illness and an addiction treatment program.
    Kleber HD
    Ann N Y Acad Sci; 1982; 398():173-7. PubMed ID: 6961854
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment of heroin addiction by methadone. Specialized care].
    Laqueille X
    Ann Med Interne (Paris); 1994 Nov; 145 Suppl 3():41-2. PubMed ID: 7880015
    [No Abstract]   [Full Text] [Related]  

  • 3. Limit setting on drug abuse in methadone maintenance patients.
    McCarthy JJ; Borders OT
    Am J Psychiatry; 1985 Dec; 142(12):1419-23. PubMed ID: 4073304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Day treatment versus enhanced standard methadone services for opioid-dependent patients: a comparison of clinical efficacy and cost.
    Avants SK; Margolin A; Sindelar JL; Rounsaville BJ; Schottenfeld R; Stine S; Cooney NL; Rosenheck RA; Li SH; Kosten TR
    Am J Psychiatry; 1999 Jan; 156(1):27-33. PubMed ID: 9892294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug treatment of opioid dependence.
    Minovitz O
    CMAJ; 1988 Mar; 138(6):496. PubMed ID: 3345474
    [No Abstract]   [Full Text] [Related]  

  • 6. Addiction is a Chronic Medical Illness.
    Morse ED
    N C Med J; 2018; 79(3):163-165. PubMed ID: 29735618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Long term effectiveness of methadone maintenance treatments in persons with addiction to opiates].
    Bobes García J; Bobes Bascarán MT
    Adicciones; 2012; 24(3):179-83. PubMed ID: 22868972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rationale for maintenance pharmacotherapy of opiate dependence.
    Kreek MJ
    Res Publ Assoc Res Nerv Ment Dis; 1992; 70():205-30. PubMed ID: 1346939
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alcohol-abusing methadone patients.
    Brewer C
    Alcohol Clin Exp Res; 1994 Jun; 18(3):767-8. PubMed ID: 7943689
    [No Abstract]   [Full Text] [Related]  

  • 10. [The treatment of drug dependence on opiates by methadone chlorhydrate (author's transl)].
    Roux JM; Benyacoub A; Perron JL; Hantzberg P; Mortier L; Quinquis MN
    Neuropsychiatr Enfance Adolesc; 1980; 28(7-8):285-9. PubMed ID: 7413024
    [No Abstract]   [Full Text] [Related]  

  • 11. Survival analysis in drug program evaluation. Part II. Partitioning treatment effects.
    Anglin MD; Fisher DG
    Int J Addict; 1987 Apr; 22(4):377-87. PubMed ID: 3583484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. On the usefulness of therapeutic drug monitoring of methadone.
    Eap CB
    Eur Addict Res; 2000 Mar; 6(1):31-3. PubMed ID: 10729740
    [No Abstract]   [Full Text] [Related]  

  • 13. [Rational control analysis within the scope of a methadone program].
    Wehinger G; Battista HJ
    Beitr Gerichtl Med; 1990; 48():703-11. PubMed ID: 2241862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comprehensive care of drug addiction during a 5-year period at the methadone center in Prague].
    Popov P; Becka J; Wilczek H
    Vnitr Lek; 2003 Nov; 49(11):851-8. PubMed ID: 14689681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methadone maintenance treatment may improve completion rates and delay opioid relapse for opioid dependent individuals under community corrections supervision.
    Clark CB; Hendricks PS; Lane PS; Trent L; Cropsey KL
    Addict Behav; 2014 Dec; 39(12):1736-40. PubMed ID: 25117851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Problems in methadone treatment: the influence of reference groups.
    Hunt DE; Lipton DS; Goldsmith DS; Strug DL
    NIDA Res Monogr; 1984; 46():8-22. PubMed ID: 6427626
    [No Abstract]   [Full Text] [Related]  

  • 17. New hot topics sections: 1. China's new march forward in addiction treatment: methadone for the masses. 2. Issues in formulating DSM V.
    Kosten TR; Gardner TJ
    Am J Drug Alcohol Abuse; 2008; 34(2):123-6. PubMed ID: 18293228
    [No Abstract]   [Full Text] [Related]  

  • 18. Changes in the dose levels of opiates used by addicts admitted for withdrawal between 1969-1979.
    McCafferty L; Gossop M
    Br J Addict; 1981 Mar; 76(1):91-5. PubMed ID: 6937213
    [No Abstract]   [Full Text] [Related]  

  • 19. Narcotic addiction and methadone treatment in Hong Kong: lessons for the United States.
    Newman RG
    J Public Health Policy; 1985 Dec; 6(4):526-38. PubMed ID: 4093503
    [No Abstract]   [Full Text] [Related]  

  • 20. The impact of ongoing illicit drug use on methadone adherence in illicit drug users receiving treatment for HIV in a directly observed therapy program.
    Raffa JD; Grebely J; Tossonian H; Wong T; Viljoen M; Khara M; Mead A; McLean M; Duncan F; Petkau AJ; DeVlaming S; Conway B
    Drug Alcohol Depend; 2007 Jul; 89(2-3):306-9. PubMed ID: 17383117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.